DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, featuring promising progress across many clinical and industrial purposes. With its structural similarity to In a natural way derived human serum albumin, OsrHSA gives a safer, additional responsible choice for therapeutic use, speci